Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
about
Insights into human immunodeficiency virus-hepatitis B virus co-infection in IndiaHepatitis B and A vaccination in HIV-infected adults: A reviewOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationA multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet NamHigh proportion of HIV serodiscordance among HIV-affected married couples in northern VietnamDetection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected IndividualsHepatitis B virus and its sexually transmitted infection - an update.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Joint modeling of HIV data in multicenter observational studies: A comparison among different approaches.Health-related quality of life among military HIV patients on antiretroviral therapy.Vaccination in HIV-infected adults.Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: high prevalence of occult hepatitis B and F3 subgenotype dominanceHepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a DecadeThe Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in MalawiPrevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia.Chronic bystander infections and immunity to unrelated antigens.Towards the elimination and eradication of hepatitis B.Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.Evaluation of longitudinal clinical outcomes and adherence to care among HIV-infected refugees.Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland.Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.HBV infection in untreated HIV-infected adults in Maputo, Mozambique.A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.Hepatitis B virus vaccination in HIV-infected people: A review.HIV-hepatitis B virus co-infection: epidemiology, pathogenesis, and treatment.Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.Cryptococcemia in primary HIV infection.Achieving protection against HBV in HIV patients: Finding the best strategy.HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.HBV and HIV co-infection: Prevalence and clinical outcomes in tertiary care hospital Malaysia.HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study.Reply to Tsai et al.Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users.
P2860
Q26797826-DD1C1FBD-0469-493E-B182-9DFB060C0905Q26799782-82815C74-3C79-4AC2-9864-CBC10284ECC1Q26864478-22F771DC-53B7-41EC-A102-29815F97A952Q28480392-769E69A8-459C-4E6F-A3C7-360C60773A2AQ28546629-16E98306-A147-4CD2-B94E-A984FD78C56DQ28548313-C60AE022-F907-4991-8F49-7990B4508A50Q30235028-E93CDFC4-524A-4882-A8EA-AF0C0A803C5DQ30391932-E7C3236C-C5EB-4FBC-B7A5-95A0FD94E48CQ30786463-21B03C43-0637-4BC6-A842-9F2C1DCABD37Q33773075-2A9D7F42-D6B4-4BF3-A465-554EA399A722Q33980764-F377FF14-E66A-406A-B3AB-3FC7AA46700DQ34405008-DC6892BB-E84F-4A5C-9ACA-1AFA351BACE5Q34437586-7F614E88-F6B4-478A-B15F-80E498E218FEQ34612595-4EAC4EE5-883D-4052-9780-5DBD9A15E41DQ35775807-705FCBA4-D574-4B84-8F2F-65157EAAE9C9Q36178032-DDE6CAA7-E24D-4C42-A7A0-FE15C93C908AQ36293979-337808B2-918F-402D-8A29-9EF40784E2F7Q36399193-22A3DBEA-A945-41CD-AC14-4C3BBCA08DFAQ36550395-FFC41377-56F3-4374-BAF6-146423E24BAFQ36743201-7684E622-4AFF-44C1-B099-74A8E9A9F04DQ37098214-B25AFA0C-0D0C-4D6A-A5B2-5E0D9C99E28DQ37632401-BE7C918C-C908-432C-B1DD-20102BC8F1E6Q37664254-8C1015CA-BDDC-4C48-8DEB-865C7B4A2EC8Q37700789-834E533E-7741-4190-97D3-C25549BA5839Q38130927-96E21B7D-8B61-4909-A172-7D96D697DB00Q38637823-125A2793-08DF-4201-884E-2DB241D0F0A0Q38639401-E9718164-2731-40D3-AF58-3922D540F9C8Q38651617-B2F247CB-E179-4D7E-8D8B-BC3BDB45E822Q38657651-5D83DF25-0990-48B5-AF29-D1B945A622AFQ39166033-4A0E012D-AAE4-4B12-8EC4-0686E58A4FF6Q39425755-C11F1F51-CA91-4DB9-80A4-B3A3BEE700ADQ39503010-3E937B54-7F84-425F-AB65-0139CEBCAC0FQ40481396-17F648EB-F81C-457D-81B5-CF5EFE03DD29Q40527467-1EC0712D-4876-494D-8BB7-32FD540FD78AQ40627202-325BDC3A-7374-4B34-9B9B-3DB88D04A6E5Q40644696-992CB005-030B-4D52-81D5-EFB436A8BEC2Q41546085-BF38B402-28CC-4BA2-9C1A-80B53AE198E2Q42253134-74013C54-222A-4DB9-BEED-9641EE850C16Q42584125-3D66AAFB-1AF6-493B-808D-492C7D85D840Q42982907-EE7A2430-F01F-4771-BF8B-0A7B3AFB1267
P2860
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@ast
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@en
type
label
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@ast
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@en
prefLabel
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@ast
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@en
P2093
P2860
P356
P1476
Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters
@en
P2093
Amy C Weintrob
Brian K Agan
Chloe L Thio
Glenn Wortmann
Helen M Chun
Infectious Disease Clinical Research Program HIV Working Group
Jason D Maguire
Katherine Huppler Hullsiek
Linda L Jagodzinski
Michael L Landrum
P2860
P304
P356
10.1093/INFDIS/JIR720
P407
P577
2011-12-05T00:00:00Z